Update on Non-Alcoholic Steatohepatitis; An Issue of Clinics in Liver Disease; E-Book
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xviii 7. Preface - p. xix 8. Nonalcoholic Fatty Liver Disease: Disease Burden and Disease Awareness - p. 173 9. Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis - p. 187 10. Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma - p. 211 11. Changings and Challenges in Liver Transplantation for Nonalcoholic Fatty Liver Disease/Steatohepatitis - p. 225 12. Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Cardiovascular Diseases - p. 239 13. Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Nonhepatocellular Cancers - p. 251 14. Clinics in Liver Disease: Update on Nonalcoholic Steatohepatitis: Sarcopenia and Nonalcoholic Fatty Liver Disease - p. 275 15. Nonalcoholic Fatty Liver Disease in Asia, Africa, and Middle East Region - p. 287 16. Nonalcoholic Fatty Liver Disease in Latin America and Australia - p. 301 17. Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease: An Incomplete Jigsaw Puzzle - p. 317 18. Genetic Markers Predisposing to Nonalcoholic Steatohepatitis - p. 333 19. Role of Liver Biopsy in Clinical Trials and Clinical Management of Nonalcoholic Fatty Liver Disease - p. 353 20. Roles of Radiological Tests in Clinical Trials and the Clinical Management of Nonalcoholic Fatty Liver Disease - p. 363 21. Noninvasive Tests Used in Risk Stratification of Patients with Nonalcoholic Fatty Liver Disease - p. 373 22. Current Treatment Options, Including Diet, Exercise, and Medications: The Impact on Histology - p. 397 23. The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis - p. 413 24. Future Treatment Options and Regimens for Nonalcoholic Fatty Liver Disease - p. 429 25. Special Population: Lean Nonalcoholic Fatty Liver Disease - p. 451 26. Special Population: Pediatric Nonalcoholic Fatty Liver Disease - p. 471 27. Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease - p. 483 28. Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic Fatty Liver Disease - p. 515 29. Research Priorities for Precision Medicine in NAFLD - p. 535
Update on Non-Alcoholic Steatohepatitis; An Issue of Clinics in Liver Disease; E-Book
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xviii 7. Preface - p. xix 8. Nonalcoholic Fatty Liver Disease: Disease Burden and Disease Awareness - p. 173 9. Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis - p. 187 10. Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma - p. 211 11. Changings and Challenges in Liver Transplantation for Nonalcoholic Fatty Liver Disease/Steatohepatitis - p. 225 12. Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Cardiovascular Diseases - p. 239 13. Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Nonhepatocellular Cancers - p. 251 14. Clinics in Liver Disease: Update on Nonalcoholic Steatohepatitis: Sarcopenia and Nonalcoholic Fatty Liver Disease - p. 275 15. Nonalcoholic Fatty Liver Disease in Asia, Africa, and Middle East Region - p. 287 16. Nonalcoholic Fatty Liver Disease in Latin America and Australia - p. 301 17. Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease: An Incomplete Jigsaw Puzzle - p. 317 18. Genetic Markers Predisposing to Nonalcoholic Steatohepatitis - p. 333 19. Role of Liver Biopsy in Clinical Trials and Clinical Management of Nonalcoholic Fatty Liver Disease - p. 353 20. Roles of Radiological Tests in Clinical Trials and the Clinical Management of Nonalcoholic Fatty Liver Disease - p. 363 21. Noninvasive Tests Used in Risk Stratification of Patients with Nonalcoholic Fatty Liver Disease - p. 373 22. Current Treatment Options, Including Diet, Exercise, and Medications: The Impact on Histology - p. 397 23. The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis - p. 413 24. Future Treatment Options and Regimens for Nonalcoholic Fatty Liver Disease - p. 429 25. Special Population: Lean Nonalcoholic Fatty Liver Disease - p. 451 26. Special Population: Pediatric Nonalcoholic Fatty Liver Disease - p. 471 27. Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease - p. 483 28. Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic Fatty Liver Disease - p. 515 29. Research Priorities for Precision Medicine in NAFLD - p. 535
